Cargando…
Targeting PVT1 Exon 9 Re-Expresses Claudin 4 Protein and Inhibits Migration by Claudin—Low Triple Negative Breast Cancer Cells
SIMPLE SUMMARY: Triple negative breast cancer accounts for 10–15% of all breast cancers. Specific molecular characteristics have led to the identification of six subtypes of triple negative breast cancer, with one in particular being claudin-low. PVT1, a non-protein coding gene, has been demonstrate...
Autores principales: | Levine, Fayola, Ogunwobi, Olorunseun O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958609/ https://www.ncbi.nlm.nih.gov/pubmed/33801373 http://dx.doi.org/10.3390/cancers13051046 |
Ejemplares similares
-
Long Noncoding RNA from PVT1 Exon 9 Is Overexpressed in Prostate Cancer and Induces Malignant Transformation and Castration Resistance in Prostate Epithelial Cells
por: Pal, Gargi, et al.
Publicado: (2019) -
PVT1 Exon 9: A Potential Biomarker of Aggressive Prostate Cancer?
por: Ilboudo, Adeodat, et al.
Publicado: (2015) -
Editorial: PVT1 in Cancer
por: Ogunwobi, Olorunseun O., et al.
Publicado: (2020) -
Chemoresistance Mediated by ceRNA Networks Associated With the PVT1 Locus
por: Ogunwobi, Olorunseun O., et al.
Publicado: (2019) -
Re-definition of claudin-low as a breast cancer phenotype
por: Fougner, Christian, et al.
Publicado: (2020)